UBS Group
GDRX icon

UBS Group’s GoodRx Holdings GDRX Stock Holding History

UBS Group’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-125,000
Closed -$2.42M – 10534
2022
Q1 		$2.42M Buy
125,000
+100,000
+400% +$2.29M ﹤0.01% 3253
2021
Q4 		$817K Sell
25,000
-75,000
-75% -$3.02M ﹤0.01% 4563
2021
Q3 		$4.1M Buy
+100,000
New +$3.63M ﹤0.01% 2886

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group's GDRX Position: Q2 2026 in Review

UBS Group reduced its GoodRx Holdings (GDRX) stake by 45% in Q2 2026, selling an estimated $946K and leaving 454,795 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #5496.

UBS Group first reported a position in GDRX in Q3 2020 and has held it in 24 quarters since. The position peaked at $37.2M in Q1 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • UBS Group held 454,795 shares of GoodRx Holdings worth $1.31M as of Q2 2026.
  • UBS Group sold 372,117 GoodRx Holdings shares in Q2 2026, an estimated $946K.
  • GoodRx Holdings made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5496 holding.
  • UBS Group first reported a position in GoodRx Holdings in Q3 2020 and has held it in 24 quarters since.
  • UBS Group's GoodRx Holdings position peaked at $37.2M in Q1 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.